价格

low dose interleukin-2

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

USE OF LOW DOSE IL-2 FOR TREATING TYPE 1 DIABETES
EP 2683395 B2申请人: HOPITAUX PARIS ASSIST PUBLIQUE优先权: 2011
CN
EP
US
WO
8 件公开
Method for stimulating T lymphocytes with IL-2
US 9669071 B2申请人: KLATZMANN DAVID优先权: 2012
US
8 件公开
LOW DOSE HUMAN INTERLEUKIN-2 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
EP 4647123 A2申请人: CENTRE HOSPITALIER UNIV DE NIMES优先权: 2020
EP
US
WO
6 件公开
NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE
- EP 4788364 A1
  申请人: US HEALTH优先权: 2023
  CN
  EP
  WO
  3 件公开
- US 20240024479 A1
  申请人: US HEALTH优先权: 2023
  US
NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE
US 20240238339 A1申请人: US HEALTH优先权: 2020
CN
US
2 件公开
New indication of human interleukin-2 and antituberculotic combination medicine
CN 1326783 A申请人: HOU YUNDE优先权: 2000
CN
Method of inducing cell-mediated protective immunity against HIV using low doses of immunogens
US 2001043932 A1申请人: SECRETARY OF THE DEPT OF HEALT优先权: 2001
US
Application of ursolic acid to antitumor immunity
CN 103142620 A申请人: XINJIANG TECH INST PHYSICS CAS优先权: 2013
CN
Application of low-dose interleukin 2 in treatment of immune-related diseases
CN 104189892 A申请人: UNIV PEKING PEOPLES HOSPITAL优先权: 2014
CN
Application of recombinant human calcineurin B subunit
CN 105435215 A申请人: HAIKOU QILI PHARMACEUTICAL CO LTD优先权: 2015
CN

药物

low dose interleukin-2

专利

NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE